Concepedia
Statistics
Publications
8
Citations
616
H-Index
Active since
1997
Affiliations
Epizyme (United States)(Current)
KU Leuven
Dana-Farber Cancer Institute
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Laura Sierra is an author at Epizyme (United States) specializing in medicine, oncology, and malignant neoplasms.
Publications per year
1997–2025
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Mrinal M. Gounder, Patrick Schöffski, Robin L. Jones et al. · The Lancet Oncology · 2020 · 406 citations
Medicine, Cancer Biology, Oncology +12
Safety and efficacy of tazemetostat, a first-in-class EZH2 inhibitor, in patients (pts) with epithelioid sarcoma (ES) (NCT02601950).
Silvia Stacchiotti, Patrick Schöffski, Robin L. Jones et al. · Journal of Clinical Oncology · 2019 · 66 citations
Medicine, Oncology, Pharmacology +15
Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma
Atreyi Dasgupta, Laura Sierra, Susan V. Tsang et al. · Cancer Research · 2020 · 37 citations · Full text
Medicine, Oncology, Pharmacology +17
Phase I study of tazemetostat, an enhancer of zeste homolog-2 inhibitor, in pediatric pts with relapsed/refractory integrase interactor 1-negative tumors.
Susan Chi, Franck Bourdeaut, Theodore W. Laetsch et al. · Journal of Clinical Oncology · 2020 · 33 citations
Medicine, Oncology, Pharmacology +16
Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement
Daniel Hagemeyer, Anas Merdad, Laura Sierra et al. · JACC: Cardiovascular Interventions · 2024 · 20 citations
Medicine, Cardiology, Surgery +16
1–5 of 8